» Articles » PMID: 39273694

Experimental Cell Models for Investigating Neurodegenerative Diseases

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Sep 14
PMID 39273694
Authors
Affiliations
Soon will be listed here.
Abstract

Experimental models play a pivotal role in biomedical research, facilitating the understanding of disease mechanisms and the development of novel therapeutics. This is particularly true for neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, and motor neuron disease, which present complex challenges for research and therapy development. In this work, we review the recent literature about experimental models and motor neuron disease. We identified three main categories of models that are highly studied by scientists. In fact, experimental models for investigating these diseases encompass a variety of approaches, including modeling the patient's cell culture, patient-derived induced pluripotent stem cells, and organoids. Each model offers unique advantages and limitations, providing researchers with a range of tools to address complex biological questions. Here, we discuss the characteristics, applications, and recent advancements in terms of each model system, highlighting their contributions to advancing biomedical knowledge and translational research.

Citing Articles

Biomarkers in Hereditary Spastic Paraplegias.

Panza E, Orlacchio A Int J Mol Sci. 2025; 26(5).

PMID: 40076577 PMC: 11899947. DOI: 10.3390/ijms26051950.


Skin and Induced Pluripotent Stem Cells as Biomarkers for Neurodegenerative Diseases.

Rallis E, Grech V, Lotsaris K, Tertipi N, Sfyri E, Kefala V Genes (Basel). 2025; 15(12.

PMID: 39766775 PMC: 11675334. DOI: 10.3390/genes15121507.

References
1.
van der Lee S, Wolters F, Ikram M, Hofman A, Ikram M, Amin N . The effect of APOE and other common genetic variants on the onset of Alzheimer's disease and dementia: a community-based cohort study. Lancet Neurol. 2018; 17(5):434-444. DOI: 10.1016/S1474-4422(18)30053-X. View

2.
Jothi D, Kulka L . Strategies for modeling aging and age-related diseases. NPJ Aging. 2024; 10(1):32. PMC: 11237002. DOI: 10.1038/s41514-024-00161-5. View

3.
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K . Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131(5):861-72. DOI: 10.1016/j.cell.2007.11.019. View

4.
Duan L, Yu X . Fibroblasts: New players in the central nervous system?. Fundam Res. 2024; 4(2):262-266. PMC: 11197739. DOI: 10.1016/j.fmre.2023.01.014. View

5.
Oshkolova A, Grekhnev D, Kruchinina A, Belikova L, Volovikov E, Lebedeva O . Comparison of the calcium signaling alterations in GABA-ergic medium spiny neurons produced from iPSCs of different origins. Biochimie. 2024; 222:63-71. DOI: 10.1016/j.biochi.2023.12.011. View